These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 11301351

  • 1. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A, Oda Y, Adachi T, Oshiro Y, Tamiya S, Tanaka K, Matsuda S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
    [Abstract] [Full Text] [Related]

  • 2. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A, Oda Y, Adachi T, Tamiya S, Matsuda S, Tanaka K, Iwamoto Y, Tsuneyoshi M.
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS.
    Anticancer Res; 1996 Feb; 16(4A):2009-15. PubMed ID: 8712735
    [Abstract] [Full Text] [Related]

  • 4. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y, Sugimura H, Sato A, Hirabayashi T, Kanda H, Kitagawa T, Kawaguchi N, Imamura T, Machinami R.
    Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
    [Abstract] [Full Text] [Related]

  • 5. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C, Castresana JS, Ruiz J, Kreicbergs A.
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [Abstract] [Full Text] [Related]

  • 6. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I, Zaravinos A, Karyotis I, Delakas D, Spandidos DA.
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [Abstract] [Full Text] [Related]

  • 7. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
    Rozeman LB, Hameetman L, van Wezel T, Taminiau AH, Cleton-Jansen AM, Hogendoorn PC, Bovée JV.
    J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
    [Abstract] [Full Text] [Related]

  • 8. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients.
    Cuatrecasas M, Erill N, Musulen E, Costa I, Matias-Guiu X, Prat J.
    Cancer; 1998 Mar 15; 82(6):1088-95. PubMed ID: 9506354
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K, Murata H, Takeshita H, Hirata M, Hashiguchi S, Tsuji Y, Nakamura S, Ashihara T, Hirasawa Y.
    Mod Pathol; 1999 Sep 15; 12(9):863-72. PubMed ID: 10496594
    [Abstract] [Full Text] [Related]

  • 10. Dedifferentiation of low grade chondrosarcomas.
    McFarland GB, McKinley LM, Reed RJ.
    Clin Orthop Relat Res; 1977 Sep 15; (122):157-64. PubMed ID: 837602
    [Abstract] [Full Text] [Related]

  • 11. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
    Weise B, Ghebremedhin E, Zschunke F, Radzun HJ.
    Gen Diagn Pathol; 1996 Jun 15; 142(1):45-52. PubMed ID: 8793486
    [Abstract] [Full Text] [Related]

  • 12. [Poorly differentiated ("dedifferentiated") chondrosarcoma].
    Petrovichev NN, Eremina LA, Khmelev LA, Kasumov NV.
    Vopr Onkol; 1984 Jun 15; 30(1):8-13. PubMed ID: 6695530
    [Abstract] [Full Text] [Related]

  • 13. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET, Zafiropoulos A, Arvanitis DA, Spandidos DA.
    Eye (Lond); 2005 Feb 15; 19(2):210-4. PubMed ID: 15232598
    [Abstract] [Full Text] [Related]

  • 14. Rb-loss is associated with high malignancy in chondrosarcoma.
    Röpke M, Boltze C, Meyer B, Neumann HW, Roessner A, Schneider-Stock R.
    Oncol Rep; 2006 Jan 15; 15(1):89-95. PubMed ID: 16328039
    [Abstract] [Full Text] [Related]

  • 15. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
    Bohle RM, Brettreich S, Repp R, Borkhardt A, Kosmehl H, Altmannsberger HM.
    Am J Pathol; 1996 Mar 15; 148(3):731-8. PubMed ID: 8774129
    [Abstract] [Full Text] [Related]

  • 16. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
    Demunter A, Ahmadian MR, Libbrecht L, Stas M, Baens M, Scheffzek K, Degreef H, De Wolf-Peeters C, van Den Oord JJ.
    Cancer Res; 2001 Jun 15; 61(12):4916-22. PubMed ID: 11406571
    [Abstract] [Full Text] [Related]

  • 17. H-ras mutation is an additional event of sarcomatous transformation in aerodigestive spindle cell carcinoma.
    Shiratsuchi H, Hirakawa N, Saito T, Oda Y, Yamamoto H, Tomita K, Yamamoto T, Tsuneyoshi M.
    Oncol Rep; 2004 Mar 15; 11(3):597-604. PubMed ID: 14767509
    [Abstract] [Full Text] [Related]

  • 18. [Clinico-morphological characteristics of bone chondrosarcomas].
    Petrovichev NN, Eremina LA, Kasumov NV.
    Vopr Onkol; 1984 Mar 15; 30(4):14-20. PubMed ID: 6730402
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM, Rozeman LB, Taminiau AH, Sciot R, Bovée JV, Cleton-Jansen AM, Hogendoorn PC.
    J Pathol; 2004 Mar 15; 202(3):359-66. PubMed ID: 14991902
    [Abstract] [Full Text] [Related]

  • 20. [K-ras gene mutation in gallbladder carcinoma].
    Roa JC, Roa I, de Aretxabala X, Melo A, Faría G, Tapia O.
    Rev Med Chil; 2004 Aug 15; 132(8):955-60. PubMed ID: 15478297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.